Key result
This review highlights recent advances in platelet proteomics, emphasizing the potential of targeted quantification methods for identifying novel biomarkers and antiplatelet therapeutic targets.
Why the study?
Recent advances in proteomics have provided insights into platelet biology and responses across pathophysiological pathways, creating opportunities to characterize platelet functions, identify biomarkers, and uncover novel therapeutic targets.
This review highlights the potential of quantitative platelet proteomics for identifying novel biomarkers and antiplatelet therapeutic targets.
Answers are grounded in this paper and cite their sources.
Advances in platelet proteomics merit prospective validation; leaves open their role in guiding antiplatelet therapy.
Platelets are a heterogeneous small anucleate blood cell population with a central role both in physiological haemostasis and in pathological states, spanning from thrombosis to inflammation, and cancer. Recent advances in proteomic studies provided additional important information concerning the platelet biology and the response of platelets to several pathophysiological pathways. Platelets circulate systemically and can be easily isolated from human samples, making proteomic application very interesting for characterizing the complexity of platelet functions in health and disease as well as for identifying and quantifying potential platelet proteins as biomarkers and novel antiplatelet therapeutic targets. To date, the highly dynamic protein content of platelets has been studied in resting and activated platelets, and several subproteomes have been characterized including platelet-derived microparticles, platelet granules, platelet releasates, platelet membrane proteins, and specific platelet post-translational modifications. In this review, a critical overview is provided on principal platelet proteomic studies focused on platelet biology from signaling to granules content, platelet proteome changes in several diseases, and the impact of drugs on platelet functions. Moreover, recent advances in quantitative platelet proteomics are discussed, emphasizing the importance of targeted quantification methods for more precise, robust and accurate quantification of selected proteins, which might be used as biomarkers for disease diagnosis, prognosis and therapy, and their strong clinical impact in the near future.
No takes yet. Share an insight, caveat, or question.
Gianazza et al. (2020) conducted a review in Platelet biology in health and disease. This review highlights recent advances in platelet proteomics, emphasizing the potential of targeted quantification methods for identifying novel biomarkers and antiplatelet therapeutic targets.
Synapse has enriched 10 related papers. Consider them for comparative context: